Kazuya Iwabuchi
1*
Luc Van Kaer
2*The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Immunol.
Sec. T Cell Biology
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1490010
This article is part of the Research Topic Community Series in the Role of CD1- and MR1-restricted T cells in Immunity and Disease: Volume II View all 18 articles
Editorial: Community Series in the Role of CD1-and MR1-restricted T Cells in Immunity and Disease, Volume II
Provisionally accepted- 1 Kitasato University Medical Center, Kitamoto, Japan
- 2 Vanderbilt University Medical Center, Nashville, United States
Keywords: CD1, MR1, natural killer T cells, Mucosal-associated invariant T cells, nonpeptide antigens, Immunity, Immune-mediated disease, Unconventional T cells
Received: 02 Sep 2024; Accepted: 04 Sep 2024.
Copyright: © 2024 Iwabuchi and Van Kaer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Kazuya Iwabuchi, Kitasato University Medical Center, Kitamoto, 3648501, Japan
Luc Van Kaer, Vanderbilt University Medical Center, Nashville, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.